Old Web
English
Sign In
Acemap
>
authorDetail
>
J. Craig Hartman
J. Craig Hartman
Pharmacology
Internal medicine
Medicine
Cardiology
Lusitropy
4
Papers
18
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Intravenous Infusion of the Novel HNO Donor BMS-986231 Is Associated With Beneficial Inotropic, Lusitropic, and Vasodilatory Properties in 2 Canine Models of Heart Failure
2018
JACC: Basic to Translational Science
J. Craig Hartman
Carlos del Rio
John Reardon
Kefei Zhang
Hani N. Sabbah
Show All
Source
Cite
Save
Citations (9)
CXL-1020, a Novel Nitroxyl (HNO) Prodrug, Is More Effective than Milrinone in Models of Diastolic Dysfunction—A Cardiovascular Therapeutic: An Efficacy and Safety Study in the Rat
2017
Frontiers in Physiology
Steve R. Roof
Yukie Ueyama
Reza Mazhari
Robert L. Hamlin
J. Craig Hartman
Mark T. Ziolo
John Reardon
Carlos del Rio
Show All
Source
Cite
Save
Citations (9)
Differing Effects Of Ambrisentan And Bosentan On Pulmonary Fibrosis And Lung Mechanics Following Bleomycin Instillation
2011
ATS | American Thoracic Society International Conference
John T. Liles
Kristin M. Joly
Kyle Wagner
Clifford D. Wright
J. Craig Hartman
Craig F Plato
Show All
Source
Cite
Save
Citations (0)
Section Review Cardiovascular & Renal: Bradykinin degradation: potential pathways for cardiovascular therapeutic use
1996
Expert Opinion on Investigational Drugs
John A Schriefer
J. Craig Hartman
Show All
Source
Cite
Save
Citations (0)
1
map